🇺🇸 FDA
Patent

US 10500175

Compositions and methods for the treatment of cancer

granted A61KA61K31/137A61K31/19

Quick answer

US patent 10500175 (Compositions and methods for the treatment of cancer) held by KoDiscovery, LLC expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KoDiscovery, LLC
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/137, A61K31/19, A61K31/202, A61K31/33